Can Cefazolin and Linezolid Be Given Together?
Yes, cefazolin and linezolid can be safely administered together—they are physically compatible when mixed and have no clinically significant drug interactions. This combination is explicitly supported by IDSA guidelines for certain infections and has been studied for both pharmaceutical compatibility and clinical use.
Physical Compatibility
The drugs are physically and chemically compatible when admixed:
- Linezolid 200 mg/100 mL mixed with cefazolin 1 gram remains stable for 7 days at 4°C and 3 days at 23°C 1
- Solutions remain clear with no turbidity or particulate formation
- No chemical degradation of either drug occurs within these timeframes
Drug Interaction Profile
No pharmacokinetic interactions exist between these agents 2:
- Linezolid does not inhibit or induce cytochrome P450 enzymes
- Cefazolin (a beta-lactam) is not metabolized via pathways affected by linezolid
- The FDA label specifically states that linezolid pharmacokinetics are unaltered when co-administered with other antibacterial drugs, including beta-lactams
Clinical Use Scenarios
MRSA Coverage in Hospitalized Patients
For hospitalized patients with complicated skin and soft tissue infections, IDSA guidelines explicitly recommend using a beta-lactam (such as cefazolin) for nonpurulent cellulitis, with modification to MRSA-active therapy (like linezolid) if no clinical response occurs 3. This supports sequential or combination use.
Pediatric Practice
A real-world study demonstrated that combining high-dose cefazolin with clindamycin (another protein synthesis inhibitor like linezolid) successfully reduced linezolid use without compromising outcomes 4. While this study used clindamycin, it validates the concept of combining cefazolin with protein synthesis inhibitors in clinical practice.
Cardiac Surgery Prophylaxis
Both drugs achieve adequate tissue penetration when used together—a study measured simultaneous concentrations of cefazolin and linezolid in sternal bone during cardiac surgery, confirming both drugs reach therapeutic levels without interference 5.
Important Caveats
The combination shows indifference (not synergy) against MRSA in vitro 6:
- Recent 2025 data shows fractional inhibitory concentration indices of 1.11 (checkerboard) and 0.99 (E-test)
- This means no enhanced killing, but also no antagonism
- The drugs work independently without interfering with each other's activity
Do not expect enhanced efficacy from the combination itself—use each drug for its specific indication rather than hoping for synergistic effects.
Practical Administration
- Can be given simultaneously via separate IV lines
- Can be admixed in the same bag if refrigerated (stable 7 days at 4°C) 1
- No dose adjustments needed for either drug when used together
- Standard dosing applies: cefazolin 1-2 grams IV every 8 hours; linezolid 600 mg IV every 12 hours
The combination is safe, compatible, and guideline-supported for appropriate clinical scenarios where coverage of both beta-lactam-susceptible organisms and MRSA is needed.